Attachment
Daszak CBP Package, p.11 · daszak_cbp:exh:00011
Page text: p.11 · original PDF
- Date
- — (unknown precision)
- Type
- attachment · document
Activity Remarks
m
k
Ty
pe
Remark
RE
MA
RK
*
DASZAK was asked publicly by NIH to retrieve the original type-specimen used by WIV for
genetic analysis, and return it to the United States. He was also asked to explain several
aspects of their collaboration, including related to cell phone data. DASZAK called the
requirements "outrageous" and does not appear to intend to comply with them
(https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirusgrant-targeted-trump)
*
DASZAK and EcoHealth has been awarded a number of contracts and grants from the U.S.
federal government. These include contracts with the DHS Chemical and Biological Threat
Division. Many items that EcoHealth studies are likely to be subject to serious non-disclosure
agreements with the U.S. government and/or be export controlled.
More background information in the kind of research that DASZAK is heavily involved in. A lot of
the funding DASZAK receives is put towards "gain of function research" also known as biological
weapons research. This research involves experimentation that aims or is expected to increase
the transmissibility and/or virulence of pathogens. Such research, when conducted by responsible
scientists, usually aims to improve understanding of disease causing agents, their interaction
with human hosts, and/or their potential to cause pandemics. The ultimate objective of such
research is to better inform public health and preparedness efforts and/or development of medical
countermeasures. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/ In gain of function
research, genome sequences are reconstructed/reformulated and are inserted into human/animal
cells to be studied on how the "new" sequence effects humans and/or animals. There is a lot of
criticism on gain of function research in regards to ethics and if the science is worth the risks
of creating a potentially harmful virus or disease.
In 2013, DASZAK was a coauthor of publication "Isolation and characterization of a bat SARS-like
coronavirus that uses the ACE2 receptor" with Zhengli SHI and Ralph BARIC. This paper is of
significance due to the first reporting of a SL-CoV-WIV1 (SARS-like coronavirus WIV1) binding to
human cells and infecting them. https://www.nature.com/articles/nature12711#Sec2 Essentially,
DASZAK and collaborators at WIV created a bat coronavirus capable of directly infecting humans.
A follow up article published in Nature magazine on 12/12/2015 titled "Engineered bat virus stirs
debate over risky research, Lab-made coronavirus related to SARS can infect human cells" debates
"whether engineering lab variants of viruses with possible pandemic potential is worth the
risks." https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research-
%201.18787
During the inspection, it is hard to say if DASZAK will be forthcoming with information.
UNCLASSIFIED//LES
UNCLASSIFIED//LES
Links shared
- journal https://www.sciencemag.org/news/2020/08/nih-imposes-outrageous-conditions-resuming-coronavirusgrant-targeted-trump
- gov https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996883/
- journal https://www.nature.com/articles/nature12711#Sec2
- journal https://www.nature.com/news/engineered-bat-virus-stirs-debate-over-risky-research